Notice of National Cancer Institute (NCI) Participation in PA-18-935 “Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)”

Notice Number: NOT-CA-20-048

Key Dates
Release Date: April 3, 2020

Related Announcements

PA-18-935, "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)."

Issued by
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Cancer Institute (NCI) is participating, effective immediately, in PA-18-935, "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)."

The following sections of PA-18-935 have been updated to reflect NCI's participation in this funding opportunity announcement.

Part 1. Overview Information

Components of Participating Organizations

National Institute on Aging (NIA)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute on Drug Abuse (NIDA)
National Institute of Mental Health (NIMH)
National Institute of Environmental Health Sciences (NIEHS)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Human Genome Research Institute (NHGRI)
National Institute on Minority Health and Health Disparities (NIMHD)

National Cancer Institute (NCI)

Catalog of Federal Domestic Assistance (CFDA) Numbers

93.866; 93.855; 93.279; 93.847; 93.242; 93.113; 93.272; 93.286; 93.172; 93.307; 93.393; 93.394; 93.395; 93.396; 93.397; 93.398; 93.399

Inquiries

Please direct all inquiries about this Notice to:

Steve White

Division of Cancer Biology

National Cancer Institute (NCI)

Email: whitest@mail.nih.gov